Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1WYY8 | ISIN: US64112L2034 | Ticker-Symbol:
Branche
Internet
Aktienmarkt
Sonstige
1-Jahres-Chart
NET SAVINGS LINK INC Chart 1 Jahr
5-Tage-Chart
NET SAVINGS LINK INC 5-Tage-Chart
ACCESSWIRE
345 Leser
Artikel bewerten:
(2)

Net Savings Link Inc: NSAV Announces Partnership with Himalaya Technologies, Inc.

LONDON, UK / ACCESSWIRE / June 4, 2024 / Net Savings Link, Inc. (OTC Pink:NSAV), a leading Web3, blockchain and digital asset technology company, announced today a strategic development partnership with Himalaya Technologies, Inc. (OTC Pink:HMLA).


Under the agreement, NSAVx.com will provide technology development and social media management services to Himalaya Technologies. Effective immediately, NSAVx.com, through its partnership with DiVinciPay.com, will integrate the EVEREST token within the DiVinciPay payment ecosystem.

NSAVx.com previously developed the EverestLPP.com, an autonomous liquidity pool (LP) platform that links capital to pre-approved token projects and the EVEREST Token for Himalaya. For more information on the EVEREST platform, visit https://www.everestlpp.com.

As part of the rebranding initiative, NSAVx.com will overhaul all social media accounts for Himalaya to enhance brand awareness and product equity. Himalaya will announce the new social media handles by June 7, 2024.

Additionally, Net Savings Link, Inc. has executed a joint venture partnership agreement with Himalaya Technologies, Inc. Under this partnership, pre-approved NSAVx.com token listings, will be funded using the Himalaya (EVERESTlpp.com) application. All fees generated from EVERESTlpp.com funding will be equally split between the two parties.

NSAV released the following statement, "To have a viable project in today's crypto marketplace, we believe the blending of CEX and DEX applications is the next migration for the Internet of Things. By partnering with Ryan and the HMLA team, we are confident this structure will bring us one step closer to achieving our goals."

Ryan Nguyen, CEO of HMLA, "At present, NSAVx.com is adding approximately 10 new listings per month. By partnering with Kevin and his NSAVx.com developers, we project that the total LP fees derived will range between $500,000 and $1,000,000 per project. Given the agreed split between our firms, we see this as a growing revenue stream for both companies."

Please make sure to join both companies Discord channels for real-time updates:

NSAVx: https://discord.gg/rnwszGvAjD
HMLA: https://discord.gg/7A5esEx9Et

About Net Savings Link, Inc.: NSAV's vision is the establishment of a fully integrated technology company, which provides turnkey technological solutions to the Web3, blockchain and digital asset industries. The Company drives innovation in the digital currency space by developing advanced blockchain technologies, digital assets, and market solutions that bridge the gap between traditional business frameworks and the future of decentralized technology. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, financial services, advisory services and information technology.

About Himalaya Technologies: (OTC: HMLA), Himalaya Technologies is a technology development company dedicated to nurturing and launching innovative projects enhanced by blockchain and AI resources.

For further information please contact NSAV at info@nsavholdinginc.com

For further information please contact NSAVx.com at hello@nsavxmail.com

The NSAV corporate website can be accessed at https://www.netsavingslinkinc.com

The NSAV CEX website can be accessed at https://nsavx.com/

The AirdropX.co website can be accessed at https://www.airdropx.co/

The Swopx.io website can be accessed at https://www.swopx.io

The NSAV Stock information website can be accessed at https://www.nsavstock.com

The NSAVx Token website can be accessed at https://www.nsavxtoken.com/nsavx-token

The NSAVx Discord Server can be accessed at https://discord.com/invite/7Q2Vv5NmKd

The NSAV Twitter account can be accessed at https://twitter.com/nsav_tech This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and
uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person.

Contact
Net Savings Link, Inc.
info@nsavholdinginc.com

Media Contact

Organization: Net Savings Link Inc
Contact Person: James Tilton
Website: https://www.nsavholdinginc.com
Email: info@nsavholdinginc.com
Contact Number: +17185698815
Address: 26 Grosvenor Street, Mayfair
Address 2: W1K4QW
City: London
Country: United Kingdom

SOURCE: Net Savings Link Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.